CA9 and neoplasm: CA-IX has been described as a promising endogenous marker of hypoxia [25,26], and a recent meta-analysis confirmed its prognostic role on overall and disease-free survival in head and neck malignancies, without, however, any sub-analysis of the different localizations, tumor size, grade, and nodal status [27].